Navigation Links
Flagship Global Health Will Host Investor Conference Call on Thursday, November 29, 2007 at 2:00 PM EST
Date:11/26/2007

NEW YORK, Nov. 26 /PRNewswire-FirstCall/ -- Flagship Global Health, Inc. (OTC Bulletin Board: FGHH) will hold a conference call at 2:00 PM EST, Thursday, November 29, 2007. Mr. Fred Nazem, Chairman, and Mr. John Flood III, CEO of Flagship Global Health will host the investor call and will be giving a detailed update on the progress that the Company has made in the past quarter as well as what is anticipated in the near future.

The dial in number is toll free, (866) 566-1240 (domestic) and (702) 495- 1185 (International), with a Conference Call ID of 25786998. Participants should call in a few minutes before 2:00 PM EST. In order to join this conference call, participants will be required to provide the Conference ID Number listed above. Re-broadcast of the conference call will be available on Flagship Global Health's website, http://www.flagshipglobalhealth.com, within a day or two after the conference call.


'/>"/>
SOURCE Flagship Global Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Flagship Global Health Hires Health Care Veteran Larsen to Head Marketing and Sales
2. John H. Flood III Named as CEO of Flagship Global Health, Inc.
3. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
4. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
5. Global Latex Conference to Showcase Vytex(TM) NRL
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
8. Briefing on a new Web resource to address global drinking water crisis
9. MDS Pharma Services Wins Award for Management of Global Malaria Trial
10. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
11. Resonant Medical Appoints New Vice President of Global Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS ... Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. ... pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... As part ... Museum today to honor the victims of the Holocaust and Nazi persecution, Center ... at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland next ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... The ... $1.6 million in charitable dental services to 1,961 people during the April 22-23 event ... at no charge to Californians who experience barriers to care, CDA Cares educates the ...
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, ... ... that develops a variety of unique liquid food supplements, announced its popular products ... of nutritional products. , ALP Nutrition® prioritizes the use of premium natural ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: